Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer - Related Studies

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003327. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		paclitaxel

5	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		Theradex